01 Aug

NHS saving extra £1.3bn from generic drugs

The National Health Service in England and Wales saved an extra £1.3 billion last year as usage of...

Read more
30 Jul

EU approves Novartis glaucoma combo

Patients with glaucoma in Europe can now get access to Novartis' Simbrinza (brin...

Read more
29 Jul

GlaxoSmithKline's China crisis has spooked shareholders

Investigation of drug firm's sales practices underline perils to all British companies of entering...

Read more
26 Jul

Too much intervention makes patients sicker

A culture of over-investigation and over-treatment is now one of the greatest threats to western...

Read more
24 Jul

Millions unnecessarily labelled pre-diabetic, health experts say

Diagnosis increases likelihood of being prescribed medicine that merely delays onset of illness,...

Read more
20 Jul

AbbVie's raised proposal for Shire gets board backing

Board of London-listed drug company in 'detailed discussions' with US pharmaceutical firm A...

Read more
18 Jul

China charges GSK foreign consultants with illegal investigation

Briton Peter Humphrey and his US wife charged with illegally obtaining private data on Chinese...

Read more
15 Jul

New pharmaceutical conduct code under fire for not going far enough

Health forum says doctors will still not be deterred from accepting money which could influence...

Read more
09 Jul

Novartis reinforces its leadership in research with new global guidelines for Investigator Initiated Trials (IITs)

Novartis released today new global guidelines for Investigator Initiated Trials (IITs).

Read more
08 Jul

Drug shows promise for effectively treating metabolic syndrome

University of Utah researchers have discovered that an enzyme involved in intracellular signaling...

Read more